Oakworth Capital’s Cumberland Pharmaceuticals CPIX Stock Holding History

Oakworth Capital’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,052	Closed	-$3.91K	–	644
2024 Q3	$3.91K	Hold	3,052	–	–	﹤0.01%	580
2024 Q2	$4.67K	Hold	3,052	–	–	﹤0.01%	578
2024 Q1	$5.13K	Hold	3,052	–	–	﹤0.01%	533
2023 Q4	$5.47K	Hold	3,052	–	–	﹤0.01%	534
2023 Q3	$5.77K	Hold	3,052	–	–	﹤0.01%	493
2023 Q2	$4.49K	Hold	3,052	–	–	﹤0.01%	544
2023 Q1	$5.95K	Hold	3,052	–	–	﹤0.01%	483
2022 Q4	$6.87K	Hold	3,052	–	–	﹤0.01%	456
2022 Q3	$7K	Hold	3,052	–	–	﹤0.01%	476
2022 Q2	$6K	Hold	3,052	–	–	﹤0.01%	476
2022 Q1	$9K	Hold	3,052	–	–	﹤0.01%	456
2021 Q4	$14K	Hold	3,052	–	–	﹤0.01%	454
2021 Q3	$8K	Hold	3,052	–	–	﹤0.01%	487
2021 Q2	$9K	Hold	3,052	–	–	﹤0.01%	480
2021 Q1	$9K	Hold	3,052	–	–	﹤0.01%	467
2020 Q4	$9K	Hold	3,052	–	–	﹤0.01%	437
2020 Q3	$10K	Hold	3,052	–	–	﹤0.01%	422
2020 Q2	$10K	Hold	3,052	–	–	﹤0.01%	402
2020 Q1	$11K	Hold	3,052	–	–	﹤0.01%	370
2019 Q4	$16K	Hold	3,052	–	–	﹤0.01%	388
2019 Q3	$18K	Hold	3,052	–	–	﹤0.01%	385
2019 Q2	$19K	Hold	3,052	–	–	﹤0.01%	426
2019 Q1	$18K	Hold	3,052	–	–	﹤0.01%	397
2018 Q4	$18K	Hold	3,052	–	–	﹤0.01%	388
2018 Q3	$17K	Hold	3,052	–	–	﹤0.01%	410
2018 Q2	$19K	Hold	3,052	–	–	﹤0.01%	398
2018 Q1	$20K	Hold	3,052	–	–	﹤0.01%	368
2017 Q4	$22K	Hold	3,052	–	–	0.01%	375
2017 Q3	$21K	Hold	3,052	–	–	0.01%	404
2017 Q2	$21K	Hold	3,052	–	–	0.01%	396
2017 Q1	$21K	Hold	3,052	–	–	0.01%	388
2016 Q4	$17K	Hold	3,052	–	–	0.01%	401
2016 Q3	$15K	Hold	3,052	–	–	0.01%	394
2016 Q2	$14K	Hold	3,052	–	–	0.01%	388
2016 Q1	$14K	Hold	3,052	–	–	0.01%	341
2015 Q4	$16K	Hold	3,052	–	–	0.01%	314
2015 Q3	$18K	Hold	3,052	–	–	0.01%	257
2015 Q2	$19K	Hold	3,052	–	–	0.01%	259
2015 Q1	$20K	Hold	3,052	–	–	0.01%	272
2014 Q4	$18K	Hold	3,052	–	–	0.01%	278
2014 Q3	$16K	Hold	3,052	–	–	0.01%	250
2014 Q2	$14K	Hold	3,052	–	–	0.01%	259
2014 Q1	$14K	Hold	3,052	–	–	0.01%	258
2013 Q4	$16K	Buy	+3,052	New	+$14.9K	0.01%	228

Other funds holding CPIX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oakworth Capital's CPIX Position: Q4 2024 in Review

Oakworth Capital sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2024, closing a stake of 3,052 shares — an estimated $3.91K sold.

Oakworth Capital first reported a position in CPIX in Q4 2013 and held it in 44 quarters. The position peaked at $22K in Q4 2017. 20 funds tracked by Wall St. Rank hold CPIX as of Q4 2024.

Oakworth Capital reported no remaining Cumberland Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Oakworth Capital sold 3,052 Cumberland Pharmaceuticals shares in Q4 2024, an estimated $3.91K.
Oakworth Capital first reported a position in Cumberland Pharmaceuticals in Q4 2013 and held it in 44 quarters.
Oakworth Capital's Cumberland Pharmaceuticals position peaked at $22K in Q4 2017.
20 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2024.

Based on Oakworth Capital's 13F filing for Q4 2024, filed 27 Jan 2025.